Stock Info Nets

Independent Financial Information Made Easy

Our AI creates

The Best Stock Graphs and Charts

Youtube Subscribe Blog GamificArt

The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.

October 16, 2023 11:59 (London Time)

GT Biopharma

Youtube Subscribe

...

Sector: Biotechnology
Ticker: GTBP
Sentiment: 0.4466
MarketCap: 10,373,280.0
High: 0.26 Low: 0.24

Open: 0.24 Close: 0.25 Change: 0.02

We programmed an AI to read Internet. This is what it found out about GT Biopharma Company Inc.

How much time have you spent trying to decide whether investing in GT Biopharma? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about GT Biopharma are: …

Concept Map

...

Semantic Network

...

Stock Summary

GT Biopharma, Inc. focuses on the development and commercialization of immuno-oncology products. It develops GTB-3550, a single-chain tri-specific recombinant fusion protein conjugate. GT.

Today's Summary

GT Biopharma Inc (GTBP) stock has fallen -2.67% while the S&P 500 has gained 0.04% as of 11:29 AM on Thursday, Oct 12. GTBP stock has a Bullish sentiment reading.

Today's News

GT Biopharma Inc (GTBP) stock has fallen -2.67% while the S&P 500 has gained 0.04% as of 11:29 AM on Thursday, Oct 12. GTBP stock has a Bullish sentiment reading.

Stock Profile

"GT Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform. It develops GTB-3550, a single-chain tri-specific recombinant fusion protein conjugate that is in Phase I clinical trial for the treatment of myelodysplastic syndromes, refractory/relapsed acute myeloid leukemia or advanced systemic mastocytosis, and CD33+ malignancies. The company is developing GTB-3650, which is in preclinical studies that target CD33 on the surface of myeloid leukemias; and GTB-5550 that is in preclinical studies for treating patients with B7-H3 positive solid tumors. GT Biopharma, Inc. has a co-development partnership agreement with Altor BioScience Corporation for the clinical development of a 161533 TriKE fusion protein for cancer therapies; and a license agreement with the Regents of the University of Minnesota to develop and commercialize cancer therapies using TriKE technology. The company was formerly known as OXIS International, Inc. and changed its name to GT Biopharma, Inc. in July 2017. GT Biopharma, Inc. was incorporated in 1965 and is based in Brisbane, California."

Keywords

The game is changing. There is a new strategy to evaluate GT Biopharma fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about GT Biopharma are: GTBP, stock, GT, Biopharma, Inc, fall, SP, and the most common words in the summary are: state, united, excipient, phase, therapeutic, sodium, overview, . One of the sentences in the summary was: GTBP stock has a Bullish sentiment reading.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #state #united #excipient #phase #therapeutic #sodium #overview.

Read more →

Related Results

...
December 06, 2023 18:38 (London Time)

GT Biopharma

GT Biopharma is generating novel immuno-oncology biopharmaceutical drugs targeting cancers such as acute myeloid leukemia, myeloids dysplastic syndr…
Sector: Biotechnology
Ticker: GTBP
Sentiment: 0.9861
MarketCap: 10,023,397.0
High: 0.24 Low: 0.24

Open: 0.24 Close: 0.24 Change: 0.0

Read more →
...
June 09, 2023 9:51 (London Time)

GT Biopharma

GT Biopharma Inc (GTBP) stock price today, news, quotes, faqs and fundamentals. Today Watchers 1,539 52-Wk Low $0.1797 52- Wk High $3.29.
Sector: Biotechnology
Ticker: GTBP
Sentiment: 0.186
MarketCap: 13,476,579.0
High: 0.42 Low: 0.35

Open: 0.37 Close: 0.36 Change: -0.01

Read more →
...
October 16, 2023 11:59 (London Time)

GT Biopharma

GT Biopharma Inc (GTBP) stock has fallen -2.67% while the S&P 500 has gained 0.04% as of 11:29 AM on Thursday, Oct 12. GTBP stock has a Bullish sent…
Sector: Biotechnology
Ticker: GTBP
Sentiment: 0.4466
MarketCap: 10,373,280.0
High: 0.26 Low: 0.24

Open: 0.24 Close: 0.25 Change: 0.02

Read more →